Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-19-018644
Filing Date
2019-07-01
Accepted
2019-07-01 17:39:55
Documents
1
Period of Report
2019-06-27

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4036
  Complete submission text file 0000899243-19-018644.txt   5535
Mailing Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428
Business Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428 404-380-9263
MADRIGAL PHARMACEUTICALS, INC. (Issuer) CIK: 0001157601 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SYNTA PHARMACEUTICALS CORP. 45 HARTWELL AVENUE LEXINGTON MA 02421
Business Address
Gollust Keith R (Reporting) CIK: 0001325712 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33277 | Film No.: 19934439